Back to today’s briefing

Story perspectives

FDA Reviews Trials Amid Concerns of Genetic Data Misuse

6/20/2025

48 10

Summary

Story summary

The FDA is urgently reviewing clinical trials that involve sending American citizens' living cells abroad, driven by alarming concerns over potential genetic data misuse. Many participants were reportedly unaware of these practices. To safeguard ethical standards, the FDA is committed to enforcing transparency and ensuring informed consent in all future trials.

1 of 1

Story summary

The FDA is urgently reviewing clinical trials that involve sending American citizens' living cells abroad, driven by alarming concerns over potential genetic data misuse. Many participants were reportedly unaware of these practices. To safeguard ethical standards, the FDA is committed to enforcing transparency and ensuring informed consent in all future trials.